[Use of raubasine in long-term therapy of obliterating arteriopathies].
D000284:Administration, Oral; D000368:Aged; D001157:Arterial Occlusive Diseases / Q000188:drug therapy*; D004341:Drug Evaluation; D006321:Heart / Q000187:drug effects; D006801:Humans; D007263:Infusions, Parenteral; D007866:Leg / Q000098:blood supply*; D008875:Middle Aged; D015016:Yohimbine / Q000008:administration & dosage / Q000009:adverse effects / Q000627:therapeutic use*
D015016:Yohimbine
Considerazioni sull'impiego della raubasina nella terapia a lungo termine delle arteriopatie obliteranti.